data_1bqf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bqf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.78 145.11 41.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.71 -5.66 83.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' MET . 3.2 m-30 -100.8 91.36 4.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -1.142 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' TYR . 2.5 mmt -43.49 133.17 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.626 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.12 99.73 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 149.6 30.32 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.93 0.87 9.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.742 2.295 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.08 -51.07 3.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.45 55.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.43 -179.31 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 1.3 m -133.84 132.73 40.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.968 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -129.28 139.01 34.41 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.372 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.73 133.45 11.47 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.516 2.144 . . . . 0.0 110.6 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.302 179.673 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.09 110.26 17.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.882 . . . . 0.0 109.156 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 1.49 59.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' MET . 1.8 m-85 -98.79 96.36 7.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -1.218 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' TYR . 9.1 mtt -44.39 165.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 131.23 50.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.982 . . . . 0.0 109.898 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -105.95 153.38 40.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.273 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.3 1.02 9.38 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.495 2.13 . . . . 0.0 110.427 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.41 -36.34 20.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.967 . . . . 0.0 109.398 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.38 -4.84 4.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -112.6 160.63 17.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -109.61 167.5 10.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -142.42 148.59 47.91 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 158.52 31.26 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.638 2.225 . . . . 0.0 110.272 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.575 HG21 ' CG ' ' A' ' 11' ' ' TYR . 3.3 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.65 152.87 40.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.01 12.39 68.23 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CG ' HG21 ' A' ' 8' ' ' VAL . 4.5 m-85 -116.65 97.96 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.92 136.27 55.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 tmm_? -78.48 121.72 24.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -86.58 156.63 56.09 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 -5.55 15.22 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.636 2.224 . . . . 0.0 110.418 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -91.86 2.04 56.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.67 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.46 56.02 3.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -157.89 148.8 21.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.432 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.92 112.6 24.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 0.0 109.5 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.05 150.96 43.2 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 143.63 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.616 2.211 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 109.621 -179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 5.2 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.279 0.562 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.11 156.41 39.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' THR . . . 68.7 9.4 58.9 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -110.93 105.16 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.45 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.452 ' SD ' ' HB ' ' A' ' 22' ' ' THR . 2.4 mtp -56.91 165.64 1.19 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mtm-85 -115.91 133.59 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.2 p -113.45 156.05 43.86 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.992 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -19.27 12.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.597 2.198 . . . . 0.0 110.283 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -18.88 65.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.05 33.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.85 -160.78 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -1.195 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.44 155.12 42.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -131.08 142.36 45.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.193 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 168.24 21.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 110.551 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.452 ' HB ' ' SD ' ' A' ' 12' ' ' MET . 5.9 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.548 ' CG2' ' CG ' ' A' ' 11' ' ' TYR . 19.3 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.63 137.23 52.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 109.378 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.28 12.78 80.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.548 ' CG ' ' CG2' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -115.56 175.9 5.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -1.149 . . . . 0.0 109.475 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -137.34 138.43 39.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.94 122.63 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.666 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -91.62 158.03 41.01 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.283 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -5.73 15.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.601 2.201 . . . . 0.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -87.85 -49.81 6.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ARG . . . 141.29 82.83 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 163.56 -166.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -1.145 . . . . 0.0 109.548 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -145.85 138.47 25.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.818 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.73 165.4 31.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.669 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.41 131.13 10.39 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.571 2.181 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 109.38 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 27.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.79 127.88 32.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.69 56.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.2 m-85 -107.51 111.86 24.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.8 126.85 30.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 109.284 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 172.34 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.662 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -148.56 159.56 38.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.274 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.1 Cg_endo -77.32 -3.68 13.93 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.487 2.124 . . . . 0.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -89.55 16.69 7.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.448 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.92 39.95 96.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 1.2 ptm180 -153.19 -171.74 4.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -1.085 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 155.1 50.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.94 149.85 72.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.95 109.7 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.751 2.301 . . . . 0.0 110.774 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.367 -0.833 . . . . 0.0 109.308 179.758 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.21 129.18 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 109.415 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 22' ' ' THR . . . 75.47 16.31 80.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -93.28 109.63 21.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -1.148 . . . . 0.0 109.366 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.0 mtp -64.95 152.48 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -111.71 157.52 20.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 18' ' ' ARG . 82.1 p -131.99 155.02 81.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.68 -24.4 8.82 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.566 2.177 . . . . 0.0 110.195 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -52.54 64.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.842 . . . . 0.0 109.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.41 44.56 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -159.06 143.94 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -1.173 . . . . 0.0 109.561 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.563 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -82.99 155.08 24.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -134.68 134.79 22.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.28 131.4 9.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.543 2.162 . . . . 0.0 110.386 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 10' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.31 55.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.18 28.29 58.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -123.63 110.24 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.484 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 156.16 9.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -109.25 148.48 30.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.306 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -136.86 150.56 70.18 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 -19.18 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.606 2.204 . . . . 0.0 110.28 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -53.6 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.02 40.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -173.53 143.76 1.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.3 m -84.12 150.44 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -125.72 150.46 68.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 131.15 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.672 2.248 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.453 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.75 112.24 5.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.33 6.27 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.51 102.58 14.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.435 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.64 106.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.2 111.11 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -69.69 151.04 96.61 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -10.21 17.1 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.55 2.167 . . . . 0.0 110.45 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.23 -47.78 40.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.59 41.54 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -158.95 175.57 13.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -1.195 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.42 117.73 24.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -105.5 159.41 29.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.321 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.27 129.94 9.83 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.664 2.242 . . . . 0.0 110.501 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 12' ' ' MET . 8.9 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.56 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.355 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.3 8.01 85.86 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.11 96.87 6.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -1.181 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 144.24 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.58 108.45 19.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -71.09 156.06 92.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 0.0 109.394 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.34 -7.09 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.556 2.171 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -79.13 -27.83 42.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.71 28.99 2.15 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -140.94 -160.35 1.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 109.355 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.37 151.93 45.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.581 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -134.59 149.83 71.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.01 143.08 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.518 2.145 . . . . 0.0 110.279 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.524 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 11' ' ' TYR . 17.1 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.236 0.541 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 127.01 31.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' HG21 ' A' ' 22' ' ' THR . . . 109.04 -26.85 14.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 4.1 m-85 -86.31 101.57 13.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtp -53.62 161.4 1.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.135 -0.978 . . . . 0.0 109.586 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -101.8 110.41 22.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.358 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -79.8 156.32 75.11 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.25 2.96 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.678 2.252 . . . . 0.0 110.458 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -99.27 11.44 39.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 24.52 62.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.8 -170.33 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.498 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 51.2 m -140.8 153.67 45.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 mmtp -135.28 155.63 78.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 147.72 24.21 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 10' ' ' GLY . 6.8 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.511 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 15.4 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.17 117.51 18.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.57 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.5 30.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.419 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.5 m-85 -118.93 96.53 5.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -1.177 . . . . 0.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -43.84 153.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 170.84 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 p -147.2 155.01 46.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.42 -19.03 13.5 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.696 2.264 . . . . 0.0 110.303 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.64 -61.54 1.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.65 68.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.83 -171.55 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -1.201 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -130.24 137.34 49.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.289 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.75 166.96 18.17 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.54 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.684 2.256 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.275 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.5 122.55 27.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.455 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.36 3.38 88.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 2.7 m-85 -92.18 149.44 21.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -1.193 . . . . 0.0 109.542 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 tpt -108.94 151.55 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.314 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -98.34 161.33 13.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.801 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.5 p -125.91 159.02 63.64 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.87 . . . . 0.0 109.398 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.7 Cg_endo -77.95 -12.53 16.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.607 2.205 . . . . 0.0 110.601 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.82 -55.6 3.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.26 60.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -162.89 158.18 22.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -1.187 . . . . 0.0 109.523 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -108.95 142.91 38.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -126.75 139.04 33.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.98 . . . . 0.0 109.437 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.29 117.14 3.73 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.476 2.118 . . . . 0.0 110.506 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.49 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 16.9 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.79 126.01 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.62 12.62 27.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -105.77 121.94 45.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 0.0 109.442 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.35 128.99 38.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.842 . . . . 0.0 109.434 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.83 138.26 31.62 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.3 p -91.06 156.41 44.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.8 0.29 9.96 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.697 2.264 . . . . 0.0 110.417 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.2 -56.27 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 79.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 178.92 130.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -1.115 . . . . 0.0 109.621 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -89.35 131.33 35.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -123.5 152.06 64.25 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.29 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 35.6 Cg_endo -77.05 156.4 34.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.555 2.17 . . . . 0.0 110.345 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 -179.837 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 ' CD1' ' A' ' 11' ' ' TYR . 28.4 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.13 123.2 20.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 14.43 49.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.525 ' CD1' HG21 ' A' ' 8' ' ' VAL . 4.1 m-85 -115.84 97.28 6.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' TYR . 7.6 tpt -45.21 108.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -72.56 142.83 48.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.438 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 1.6 p -114.04 158.36 39.6 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.63 -36.91 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.695 2.263 . . . . 0.0 110.386 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -51.53 -66.71 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.72 48.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -153.07 177.8 10.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 109.498 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.5 m -126.77 141.26 51.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.93 145.47 37.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.43 153.47 27.29 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.0 110.375 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.909 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.27 0.557 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.57 134.92 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.99 26.61 57.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.56 110.95 13.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -1.181 . . . . 0.0 109.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 117.68 12.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -70.77 -176.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.386 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.14 155.62 43.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.528 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.73 -16.72 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 110.601 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.27 -44.91 70.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.87 38.59 0.23 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.2 179.13 7.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -1.115 . . . . 0.0 109.423 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.3 m -117.15 115.4 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.72 156.09 35.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.45 -170.93 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.592 2.194 . . . . 0.0 110.461 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 109.264 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.46 45.05 28.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.39 -62.57 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -74.68 -150.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 0.0 109.68 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.84 -153.18 17.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.93 127.21 8.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.49 179.29 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.87 178.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.78 145.11 41.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.71 -5.66 83.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' MET . 3.2 m-30 -100.8 91.36 4.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -1.142 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' TYR . 2.5 mmt -43.49 133.17 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.626 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.12 99.73 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 149.6 30.32 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.93 0.87 9.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.742 2.295 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.08 -51.07 3.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.45 55.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.43 -179.31 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 1.3 m -133.84 132.73 40.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.968 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -129.28 139.01 34.41 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.372 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.73 133.45 11.47 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.516 2.144 . . . . 0.0 110.6 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 t -118.08 67.78 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.302 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -99.15 47.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.575 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.93 110.25 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.958 . . . . 0.0 109.406 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.527 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.72 108.09 19.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -106.26 13.95 28.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.242 -0.912 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -50.79 140.55 14.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.05 130.2 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.22 94.23 0.25 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.07 -151.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -1.159 . . . . 0.0 109.376 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.38 -173.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.342 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.09 110.26 17.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.882 . . . . 0.0 109.156 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 1.49 59.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' MET . 1.8 m-85 -98.79 96.36 7.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -1.218 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' TYR . 9.1 mtt -44.39 165.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 131.23 50.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.982 . . . . 0.0 109.898 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 p -105.95 153.38 40.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.273 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.3 1.02 9.38 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.495 2.13 . . . . 0.0 110.427 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.41 -36.34 20.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.967 . . . . 0.0 109.398 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.38 -4.84 4.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -112.6 160.63 17.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -109.61 167.5 10.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -142.42 148.59 47.91 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 158.52 31.26 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.638 2.225 . . . . 0.0 110.272 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t -123.19 48.73 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -90.94 166.62 12.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.06 46.58 2.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.64 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.423 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.318 0.58 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 9.6 p30 177.22 151.65 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 1.4 m-85 65.1 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.184 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 176.52 11.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.05 174.31 46.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.51 -108.18 3.25 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.46 ' O ' HG12 ' A' ' 8' ' ' VAL . 5.0 m -94.0 -71.78 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -1.201 . . . . 0.0 109.558 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.575 HG21 ' CG ' ' A' ' 11' ' ' TYR . 3.3 m -157.23 174.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.436 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.65 152.87 40.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.01 12.39 68.23 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CG ' HG21 ' A' ' 8' ' ' VAL . 4.5 m-85 -116.65 97.96 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.92 136.27 55.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 tmm_? -78.48 121.72 24.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -86.58 156.63 56.09 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 -5.55 15.22 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.636 2.224 . . . . 0.0 110.418 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -91.86 2.04 56.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.67 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.46 56.02 3.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -157.89 148.8 21.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.432 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.92 112.6 24.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 0.0 109.5 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.05 150.96 43.2 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 143.63 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.616 2.211 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -130.38 52.08 2.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 109.621 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -135.03 108.37 7.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.152 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.96 15.88 14.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.385 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.26 149.52 19.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.43 58.27 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.1 36.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.27 59.38 7.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.68 38.81 2.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.41 148.75 41.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -1.12 . . . . 0.0 109.54 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 5.2 m -48.54 170.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.11 156.41 39.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' THR . . . 68.7 9.4 58.9 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -110.93 105.16 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.45 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.452 ' SD ' ' HB ' ' A' ' 22' ' ' THR . 2.4 mtp -56.91 165.64 1.19 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mtm-85 -115.91 133.59 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.2 p -113.45 156.05 43.86 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.992 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -19.27 12.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.597 2.198 . . . . 0.0 110.283 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -18.88 65.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.05 33.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.85 -160.78 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -1.195 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.44 155.12 42.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -131.08 142.36 45.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.193 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 168.24 21.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 110.551 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' HB ' ' SD ' ' A' ' 12' ' ' MET . 5.9 t -137.99 76.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.54 82.67 1.69 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.537 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.62 137.1 20.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.423 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -170.43 178.82 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.64 96.91 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 p -149.06 162.32 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.46 62.18 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.93 -141.15 4.76 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 98.0 m -89.73 -92.22 0.13 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.218 -1.166 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.548 ' CG2' ' CG ' ' A' ' 11' ' ' TYR . 19.3 m -160.06 167.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.487 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.63 137.23 52.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 109.378 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.28 12.78 80.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.548 ' CG ' ' CG2' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -115.56 175.9 5.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -1.149 . . . . 0.0 109.475 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -137.34 138.43 39.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.94 122.63 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.666 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -91.62 158.03 41.01 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.283 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -5.73 15.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.601 2.201 . . . . 0.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -87.85 -49.81 6.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ARG . . . 141.29 82.83 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 163.56 -166.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -1.145 . . . . 0.0 109.548 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -145.85 138.47 25.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.818 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.73 165.4 31.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.669 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.41 131.13 10.39 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.571 2.181 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -107.46 42.15 1.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 109.38 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -120.42 124.65 45.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.503 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.43 104.56 3.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.449 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.82 172.92 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.1 OUTLIER -87.89 -74.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER 176.9 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.432 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.01 -166.94 42.91 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 -92.86 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.18 -178.17 3.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.103 . . . . 0.0 109.242 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 27.3 m -127.53 -177.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.79 127.88 32.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.69 56.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.2 m-85 -107.51 111.86 24.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.8 126.85 30.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 109.284 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 172.34 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.662 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -148.56 159.56 38.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.274 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.1 Cg_endo -77.32 -3.68 13.93 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.487 2.124 . . . . 0.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -89.55 16.69 7.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.448 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.92 39.95 96.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 1.2 ptm180 -153.19 -171.74 4.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -1.085 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 155.1 50.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.94 149.85 72.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.95 109.7 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.751 2.301 . . . . 0.0 110.774 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 t -101.89 43.84 1.05 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.367 -0.833 . . . . 0.0 109.308 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.89 102.86 2.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 60.57 -178.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.042 -1.036 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.394 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -55.96 130.97 45.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.05 127.07 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.53 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.57 88.53 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.19 144.83 5.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.8 51.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -93.9 -150.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -1.199 . . . . 0.0 109.537 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.23 -171.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.21 129.18 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 109.415 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 22' ' ' THR . . . 75.47 16.31 80.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -93.28 109.63 21.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -1.148 . . . . 0.0 109.366 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.0 mtp -64.95 152.48 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -111.71 157.52 20.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 18' ' ' ARG . 82.1 p -131.99 155.02 81.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.68 -24.4 8.82 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.566 2.177 . . . . 0.0 110.195 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -52.54 64.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.842 . . . . 0.0 109.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.41 44.56 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -159.06 143.94 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -1.173 . . . . 0.0 109.561 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.563 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -82.99 155.08 24.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -134.68 134.79 22.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.28 131.4 9.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.543 2.162 . . . . 0.0 110.386 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 10' ' ' GLY . 1.8 t -115.74 54.17 0.82 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -116.24 51.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.295 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -45.89 172.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.808 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.432 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 2' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 48.3 m-20 -165.0 143.94 6.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.131 -0.981 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -107.17 -86.94 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.22 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -78.8 163.01 25.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.215 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.38 70.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 -171.54 34.75 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB2' ' NH1' ' A' ' 13' ' ' ARG . 13.3 m -131.66 -142.87 0.23 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -1.102 . . . . 0.0 109.284 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m -136.26 172.29 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 0.0 109.657 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.31 55.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.18 28.29 58.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -123.63 110.24 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.484 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 156.16 9.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.503 ' NH1' ' HB2' ' A' ' 7' ' ' CYS . 11.3 mmt180 -109.25 148.48 30.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.306 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -136.86 150.56 70.18 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 -19.18 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.606 2.204 . . . . 0.0 110.28 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -53.6 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.02 40.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -173.53 143.76 1.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.3 m -84.12 150.44 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -125.72 150.46 68.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.4 Cg_endo -78.04 131.15 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.672 2.248 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -86.76 51.04 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' CD2' ' HB2' ' A' ' 21' ' ' PRO . 20.8 m-85 -90.99 54.41 2.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.466 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 56.5 -93.06 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.509 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.265 0.555 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 3' ' ' PHE . 1.2 m-20 -111.25 81.09 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' ASN . 6.2 m-85 45.12 44.66 8.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 133.26 52.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.4 -107.28 1.02 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.56 177.23 37.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 m -99.82 158.19 15.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.08 . . . . 0.0 109.506 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -147.55 178.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.75 112.24 5.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.33 6.27 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.51 102.58 14.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.435 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.64 106.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.2 111.11 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -69.69 151.04 96.61 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -10.21 17.1 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.55 2.167 . . . . 0.0 110.45 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.23 -47.78 40.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.59 41.54 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -158.95 175.57 13.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -1.195 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.42 117.73 24.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -105.5 159.41 29.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.321 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.27 129.94 9.83 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.664 2.242 . . . . 0.0 110.501 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 12' ' ' MET . 8.9 t -122.9 42.01 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.99 114.75 24.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -108.63 -35.92 6.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.427 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -164.68 48.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.247 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -45.08 -72.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.469 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -165.06 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.74 -94.48 2.0 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.01 165.77 5.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 m -105.71 155.62 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -1.216 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.93 174.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.369 -0.832 . . . . 0.0 109.475 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.56 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.355 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.3 8.01 85.86 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.11 96.87 6.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -1.181 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 144.24 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.58 108.45 19.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -71.09 156.06 92.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 0.0 109.394 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.34 -7.09 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.556 2.171 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -79.13 -27.83 42.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.71 28.99 2.15 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -140.94 -160.35 1.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 109.355 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.37 151.93 45.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.581 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -134.59 149.83 71.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.512 ' CB ' ' CE2' ' A' ' 23' ' ' PHE . 35.9 Cg_endo -78.01 143.08 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.518 2.145 . . . . 0.0 110.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -140.5 53.77 1.62 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.524 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' CE2' ' CB ' ' A' ' 21' ' ' PRO . 2.9 p90 -121.01 57.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.59 112.84 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' ASN . 8.7 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.271 0.558 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 3.5 m-80 61.9 -90.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.547 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.96 91.73 3.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m 50.52 -168.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.93 -51.05 59.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 54.32 -117.01 7.01 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -82.49 155.66 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -1.146 . . . . 0.0 109.434 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 11' ' ' TYR . 17.1 m -43.93 165.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 127.01 31.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' HG21 ' A' ' 22' ' ' THR . . . 109.04 -26.85 14.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 4.1 m-85 -86.31 101.57 13.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtp -53.62 161.4 1.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.135 -0.978 . . . . 0.0 109.586 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -101.8 110.41 22.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.358 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -79.8 156.32 75.11 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.25 2.96 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.678 2.252 . . . . 0.0 110.458 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -99.27 11.44 39.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 24.52 62.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.8 -170.33 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.498 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 51.2 m -140.8 153.67 45.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 mmtp -135.28 155.63 78.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 147.72 24.21 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 10' ' ' GLY . 6.8 t -115.67 34.19 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.17 -5.07 23.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -68.6 -14.87 63.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.517 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -103.89 -8.57 19.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.629 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 58.56 70.5 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -43.43 6.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.597 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.89 -16.6 7.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.62 -130.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.4 m -80.15 176.15 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -1.165 . . . . 0.0 109.501 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 15.4 m -105.95 -171.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.17 117.51 18.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.57 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.5 30.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.419 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.5 m-85 -118.93 96.53 5.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -1.177 . . . . 0.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -43.84 153.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 170.84 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 p -147.2 155.01 46.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.42 -19.03 13.5 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.696 2.264 . . . . 0.0 110.303 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.64 -61.54 1.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.65 68.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.83 -171.55 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -1.201 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -130.24 137.34 49.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.289 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.75 166.96 18.17 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.54 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.684 2.256 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.38 54.61 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.275 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.556 ' C ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -125.6 -15.76 5.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.574 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER 42.28 52.6 4.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.114 -0.991 . . . . 0.0 109.318 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.591 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -121.79 89.45 3.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.93 . . . . 0.0 109.579 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -82.48 134.69 35.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 t -152.94 -177.28 6.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.121 -0.987 . . . . 0.0 109.483 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.3 -165.04 13.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.31 152.78 36.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.5 m -112.67 -56.56 2.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.4 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t -149.62 -172.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.5 122.55 27.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.455 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.36 3.38 88.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.551 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 2.7 m-85 -92.18 149.44 21.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -1.193 . . . . 0.0 109.542 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 tpt -108.94 151.55 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.314 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -98.34 161.33 13.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.801 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.5 p -125.91 159.02 63.64 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.87 . . . . 0.0 109.398 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.7 Cg_endo -77.95 -12.53 16.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.607 2.205 . . . . 0.0 110.601 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.82 -55.6 3.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.26 60.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -162.89 158.18 22.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -1.187 . . . . 0.0 109.523 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -108.95 142.91 38.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -126.75 139.04 33.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.98 . . . . 0.0 109.437 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.29 117.14 3.73 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.476 2.118 . . . . 0.0 110.506 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -107.16 31.81 5.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -153.94 88.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.334 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -137.57 86.71 2.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.453 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.37 78.11 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.289 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.88 127.28 31.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.658 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 -46.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.13 -29.26 12.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.35 -169.16 25.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.454 ' O ' HG12 ' A' ' 8' ' ' VAL . 9.3 m -94.28 -66.98 0.88 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -1.128 . . . . 0.0 109.512 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.49 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 16.9 m -158.08 156.51 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.79 126.01 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.62 12.62 27.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -105.77 121.94 45.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 0.0 109.442 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.35 128.99 38.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.842 . . . . 0.0 109.434 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.83 138.26 31.62 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.3 p -91.06 156.41 44.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.8 0.29 9.96 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.697 2.264 . . . . 0.0 110.417 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.2 -56.27 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 79.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 178.92 130.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -1.115 . . . . 0.0 109.621 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -89.35 131.33 35.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -123.5 152.06 64.25 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.29 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 35.6 Cg_endo -77.05 156.4 34.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.555 2.17 . . . . 0.0 110.345 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -111.76 31.83 5.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -144.74 175.35 10.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.87 154.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.446 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -92.92 -50.83 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.53 38.82 5.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.35 -170.61 3.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.75 -109.34 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.53 149.81 5.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.21 140.97 29.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.512 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG21 ' CD1' ' A' ' 11' ' ' TYR . 28.4 m -118.04 -175.04 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.13 123.2 20.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.86 14.43 49.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' CD1' HG21 ' A' ' 8' ' ' VAL . 4.1 m-85 -115.84 97.28 6.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' TYR . 7.6 tpt -45.21 108.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -72.56 142.83 48.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.438 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 1.6 p -114.04 158.36 39.6 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.63 -36.91 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.695 2.263 . . . . 0.0 110.386 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -51.53 -66.71 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.72 48.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -153.07 177.8 10.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 109.498 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.5 m -126.77 141.26 51.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.93 145.47 37.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.43 153.47 27.29 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.0 110.375 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -111.25 37.95 2.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -126.28 10.18 7.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.21 -157.07 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.563 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.385 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.07 -174.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.935 . . . . 0.0 109.384 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.05 -60.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.2 p -155.02 136.25 14.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.05 104.76 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.16 -113.53 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.3 m -128.27 -73.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.196 -1.179 . . . . 0.0 109.459 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.2 166.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.57 134.92 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.99 26.61 57.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.56 110.95 13.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -1.181 . . . . 0.0 109.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 117.68 12.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -70.77 -176.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.386 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.14 155.62 43.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.528 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.73 -16.72 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 110.601 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.27 -44.91 70.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.87 38.59 0.23 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.2 179.13 7.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -1.115 . . . . 0.0 109.423 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.3 m -117.15 115.4 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.72 156.09 35.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.45 -170.93 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.592 2.194 . . . . 0.0 110.461 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t -131.84 26.94 4.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -106.74 -34.96 7.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.547 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 -37.18 9.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.399 -0.813 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 118.102 -0.952 . . . . 0.0 109.387 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.78 145.11 41.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 22' ' ' THR . . . 89.71 -5.66 83.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' MET . 3.2 m-30 -100.8 91.36 4.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -1.142 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' TYR . 2.5 mmt -43.49 133.17 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.626 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.12 99.73 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 149.6 30.32 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.93 0.87 9.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.742 2.295 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.08 -51.07 3.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.45 55.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.43 -179.31 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 1.3 m -133.84 132.73 40.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.968 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -129.28 139.01 34.41 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.372 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.1 Cg_endo -78.73 133.45 11.47 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.516 2.144 . . . . 0.0 110.6 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 10' ' ' GLY . 2.1 t . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.302 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -82.09 110.26 17.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.882 . . . . 0.0 109.156 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 22' ' ' THR . . . 97.02 1.49 59.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' MET . 1.8 m-85 -98.79 96.36 7.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -1.218 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' TYR . 9.1 mtt -44.39 165.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 131.23 50.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.982 . . . . 0.0 109.898 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.482 HG21 ' HD2' ' A' ' 20' ' ' LYS . 12.4 p -105.95 153.38 40.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.273 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.3 1.02 9.38 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.495 2.13 . . . . 0.0 110.427 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.41 -36.34 20.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.967 . . . . 0.0 109.398 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.38 -4.84 4.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -112.6 160.63 17.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -109.61 167.5 10.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 14' ' ' THR . 12.3 mttt -142.42 148.59 47.91 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 158.52 31.26 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.638 2.225 . . . . 0.0 110.272 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 10' ' ' GLY . 7.8 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 11' ' ' TYR . 3.3 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.65 152.87 40.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.01 12.39 68.23 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' A' ' 8' ' ' VAL . 4.5 m-85 -116.65 97.96 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.92 136.27 55.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 tmm_? -78.48 121.72 24.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -86.58 156.63 56.09 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 -5.55 15.22 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.636 2.224 . . . . 0.0 110.418 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -91.86 2.04 56.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.67 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.46 56.02 3.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -157.89 148.8 21.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.432 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.92 112.6 24.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 0.0 109.5 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.05 150.96 43.2 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 143.63 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.616 2.211 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 109.621 -179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 5.2 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.279 0.562 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.11 156.41 39.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.761 ' O ' HG22 ' A' ' 22' ' ' THR . . . 68.7 9.4 58.9 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -110.93 105.16 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.45 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.464 ' SD ' ' HB ' ' A' ' 22' ' ' THR . 2.4 mtp -56.91 165.64 1.19 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mtm-85 -115.91 133.59 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.2 p -113.45 156.05 43.86 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.992 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -19.27 12.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.597 2.198 . . . . 0.0 110.283 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -18.88 65.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.05 33.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.85 -160.78 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -1.195 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.44 155.12 42.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -131.08 142.36 45.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.193 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 168.24 21.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 110.551 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 10' ' ' GLY . 5.9 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.548 ' CG2' ' CG ' ' A' ' 11' ' ' TYR . 19.3 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.63 137.23 52.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 109.378 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.28 12.78 80.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.548 ' CG ' ' CG2' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -115.56 175.9 5.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -1.149 . . . . 0.0 109.475 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -137.34 138.43 39.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.94 122.63 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.666 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -91.62 158.03 41.01 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.283 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -5.73 15.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.601 2.201 . . . . 0.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -87.85 -49.81 6.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ARG . . . 141.29 82.83 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 163.56 -166.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -1.145 . . . . 0.0 109.548 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -145.85 138.47 25.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.818 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.73 165.4 31.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.669 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.41 131.13 10.39 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.571 2.181 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 109.38 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 27.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.79 127.88 32.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.69 56.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.2 m-85 -107.51 111.86 24.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.8 126.85 30.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 109.284 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 172.34 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.662 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -148.56 159.56 38.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.274 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.1 Cg_endo -77.32 -3.68 13.93 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.487 2.124 . . . . 0.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -89.55 16.69 7.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.448 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.92 39.95 96.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 1.2 ptm180 -153.19 -171.74 4.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -1.085 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 155.1 50.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -133.94 149.85 72.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 35.8 Cg_endo -77.95 109.7 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.751 2.301 . . . . 0.0 110.774 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.367 -0.833 . . . . 0.0 109.308 179.758 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -79.21 129.18 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 109.415 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 22' ' ' THR . . . 75.47 16.31 80.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -93.28 109.63 21.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -1.148 . . . . 0.0 109.366 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.0 mtp -64.95 152.48 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -111.71 157.52 20.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.1 p -131.99 155.02 81.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.68 -24.4 8.82 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.566 2.177 . . . . 0.0 110.195 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -52.54 64.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.842 . . . . 0.0 109.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.41 44.56 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.06 143.94 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -1.173 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.574 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -82.99 155.08 24.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -134.68 134.79 22.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.28 131.4 9.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.543 2.162 . . . . 0.0 110.386 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 10' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.31 55.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 22' ' ' THR . . . 77.18 28.29 58.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -123.63 110.24 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.484 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 156.16 9.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -109.25 148.48 30.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.306 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -136.86 150.56 70.18 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 -19.18 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.606 2.204 . . . . 0.0 110.28 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -53.6 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.02 40.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -173.53 143.76 1.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.3 m -84.12 150.44 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -125.72 150.46 68.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 131.15 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.672 2.248 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 10' ' ' GLY . 4.9 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.75 112.24 5.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.638 ' O ' HG22 ' A' ' 22' ' ' THR . . . 110.33 6.27 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.51 102.58 14.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.443 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.64 106.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.2 111.11 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -69.69 151.04 96.61 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -10.21 17.1 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.55 2.167 . . . . 0.0 110.45 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.23 -47.78 40.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.59 41.54 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -158.95 175.57 13.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -1.195 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.42 117.73 24.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -105.5 159.41 29.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.321 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.27 129.94 9.83 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.664 2.242 . . . . 0.0 110.501 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.9 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.56 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.355 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.704 ' O ' HG22 ' A' ' 22' ' ' THR . . . 83.3 8.01 85.86 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.11 96.87 6.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -1.181 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 144.24 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.58 108.45 19.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -71.09 156.06 92.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 0.0 109.394 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.34 -7.09 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.556 2.171 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -79.13 -27.83 42.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.71 28.99 2.15 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -140.94 -160.35 1.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 109.355 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.37 151.93 45.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.581 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 1.1 ptpt -134.59 149.83 71.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 35.9 Cg_endo -78.01 143.08 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.518 2.145 . . . . 0.0 110.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.8 t . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.524 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.236 0.541 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 127.01 31.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 22' ' ' THR . . . 109.04 -26.85 14.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 4.1 m-85 -86.31 101.57 13.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtp -53.62 161.4 1.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.135 -0.978 . . . . 0.0 109.586 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -101.8 110.41 22.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.358 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -79.8 156.32 75.11 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.25 2.96 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.678 2.252 . . . . 0.0 110.458 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -99.27 11.44 39.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 24.52 62.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.8 -170.33 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.498 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 51.2 m -140.8 153.67 45.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 mmtp -135.28 155.63 78.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 147.72 24.21 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 10' ' ' GLY . 6.8 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.511 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 11' ' ' TYR . 15.4 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.17 117.51 18.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.57 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.5 30.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 8' ' ' VAL . 7.5 m-85 -118.93 96.53 5.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -1.177 . . . . 0.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -43.84 153.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 170.84 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 p -147.2 155.01 46.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.42 -19.03 13.5 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.696 2.264 . . . . 0.0 110.303 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.64 -61.54 1.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.65 68.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.83 -171.55 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -1.201 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -130.24 137.34 49.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.289 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.75 166.96 18.17 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.54 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.684 2.256 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.275 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -80.5 122.55 27.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 22' ' ' THR . . . 84.36 3.38 88.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.56 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 2.7 m-85 -92.18 149.44 21.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -1.193 . . . . 0.0 109.542 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 tpt -108.94 151.55 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.314 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -98.34 161.33 13.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.801 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.5 p -125.91 159.02 63.64 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.87 . . . . 0.0 109.398 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.7 Cg_endo -77.95 -12.53 16.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.607 2.205 . . . . 0.0 110.601 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.82 -55.6 3.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.26 60.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -162.89 158.18 22.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -1.187 . . . . 0.0 109.523 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -108.95 142.91 38.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -126.75 139.04 33.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.98 . . . . 0.0 109.437 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.29 117.14 3.73 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.476 2.118 . . . . 0.0 110.506 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 10' ' ' GLY . 9.9 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 11' ' ' TYR . 16.9 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.79 126.01 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.62 12.62 27.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -105.77 121.94 45.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 0.0 109.442 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.35 128.99 38.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.842 . . . . 0.0 109.434 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.83 138.26 31.62 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.3 p -91.06 156.41 44.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.8 0.29 9.96 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.697 2.264 . . . . 0.0 110.417 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.2 -56.27 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 79.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 178.92 130.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -1.115 . . . . 0.0 109.621 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -89.35 131.33 35.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -123.5 152.06 64.25 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.29 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 35.6 Cg_endo -77.05 156.4 34.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.555 2.17 . . . . 0.0 110.345 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 -179.837 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.13 123.2 20.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 22' ' ' THR . . . 94.86 14.43 49.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.501 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 4.1 m-85 -115.84 97.28 6.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' TYR . 7.6 tpt -45.21 108.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -72.56 142.83 48.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.444 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 1.6 p -114.04 158.36 39.6 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.63 -36.91 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.695 2.263 . . . . 0.0 110.386 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -51.53 -66.71 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.72 48.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -153.07 177.8 10.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 109.498 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.5 m -126.77 141.26 51.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -118.93 145.47 37.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.0 Cg_endo -78.43 153.47 27.29 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.0 110.375 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 67.6 p . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 11' ' ' TYR . 12.4 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.27 0.557 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.57 134.92 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.99 26.61 57.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.758 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.56 110.95 13.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -1.181 . . . . 0.0 109.588 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 117.68 12.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -70.77 -176.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.386 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.14 155.62 43.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.528 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.73 -16.72 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 110.601 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.27 -44.91 70.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.87 38.59 0.23 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.2 179.13 7.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -1.115 . . . . 0.0 109.423 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.3 m -117.15 115.4 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.72 156.09 35.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.45 -170.93 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.592 2.194 . . . . 0.0 110.461 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 109.264 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 51.46 45.05 28.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.39 -62.57 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -74.68 -150.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 0.0 109.68 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.84 -153.18 17.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.93 127.21 8.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.49 179.29 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.87 178.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.78 145.11 41.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 22' ' ' THR . . . 89.71 -5.66 83.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' MET . 3.2 m-30 -100.8 91.36 4.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -1.142 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' TYR . 2.5 mmt -43.49 133.17 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.626 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.12 99.73 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 149.6 30.32 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.93 0.87 9.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.742 2.295 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.08 -51.07 3.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.45 55.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.43 -179.31 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 1.3 m -133.84 132.73 40.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.968 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -129.28 139.01 34.41 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.372 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.1 Cg_endo -78.73 133.45 11.47 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.516 2.144 . . . . 0.0 110.6 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 10' ' ' GLY . 2.1 t -118.08 67.78 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.302 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -99.15 47.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.575 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.93 110.25 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.958 . . . . 0.0 109.406 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.527 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.72 108.09 19.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -106.26 13.95 28.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.242 -0.912 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -50.79 140.55 14.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.05 130.2 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.22 94.23 0.25 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.07 -151.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -1.159 . . . . 0.0 109.376 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t -71.38 -173.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.342 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -82.09 110.26 17.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.882 . . . . 0.0 109.156 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 22' ' ' THR . . . 97.02 1.49 59.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' MET . 1.8 m-85 -98.79 96.36 7.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -1.218 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' TYR . 9.1 mtt -44.39 165.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 131.23 50.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.982 . . . . 0.0 109.898 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.482 HG21 ' HD2' ' A' ' 20' ' ' LYS . 12.4 p -105.95 153.38 40.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.273 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.3 1.02 9.38 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.495 2.13 . . . . 0.0 110.427 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.41 -36.34 20.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.967 . . . . 0.0 109.398 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.38 -4.84 4.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -112.6 160.63 17.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -109.61 167.5 10.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 14' ' ' THR . 12.3 mttt -142.42 148.59 47.91 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 158.52 31.26 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.638 2.225 . . . . 0.0 110.272 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 10' ' ' GLY . 7.8 t -123.19 48.73 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -90.94 166.62 12.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.06 46.58 2.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.64 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.423 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.318 0.58 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 9.6 p30 177.22 151.65 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 1.4 m-85 65.1 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.184 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 176.52 11.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.05 174.31 46.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.51 -108.18 3.25 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.551 ' O ' HG13 ' A' ' 8' ' ' VAL . 5.0 m -94.0 -71.78 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -1.201 . . . . 0.0 109.558 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 11' ' ' TYR . 3.3 m -157.23 174.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.436 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.65 152.87 40.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.01 12.39 68.23 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' A' ' 8' ' ' VAL . 4.5 m-85 -116.65 97.96 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.92 136.27 55.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 tmm_? -78.48 121.72 24.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -86.58 156.63 56.09 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 -5.55 15.22 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.636 2.224 . . . . 0.0 110.418 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -91.86 2.04 56.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.67 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.46 56.02 3.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -157.89 148.8 21.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.432 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.92 112.6 24.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 0.0 109.5 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.05 150.96 43.2 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 143.63 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.616 2.211 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -130.38 52.08 2.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 109.621 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -135.03 108.37 7.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.152 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.96 15.88 14.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.385 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.26 149.52 19.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.43 58.27 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.1 36.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.27 59.38 7.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.68 38.81 2.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.41 148.75 41.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -1.12 . . . . 0.0 109.54 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 5.2 m -48.54 170.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.11 156.41 39.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.761 ' O ' HG22 ' A' ' 22' ' ' THR . . . 68.7 9.4 58.9 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -110.93 105.16 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.45 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.464 ' SD ' ' HB ' ' A' ' 22' ' ' THR . 2.4 mtp -56.91 165.64 1.19 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mtm-85 -115.91 133.59 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.2 p -113.45 156.05 43.86 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.992 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -19.27 12.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.597 2.198 . . . . 0.0 110.283 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -18.88 65.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.05 33.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.85 -160.78 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -1.195 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.44 155.12 42.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -131.08 142.36 45.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.193 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 168.24 21.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 110.551 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 10' ' ' GLY . 5.9 t -137.99 76.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.54 82.67 1.69 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.537 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.62 137.1 20.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.423 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -170.43 178.82 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.64 96.91 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 p -149.06 162.32 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.46 62.18 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.93 -141.15 4.76 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.596 ' O ' HG13 ' A' ' 8' ' ' VAL . 98.0 m -89.73 -92.22 0.13 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.218 -1.166 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 7' ' ' CYS . 19.3 m -160.06 167.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.487 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.63 137.23 52.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 109.378 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.28 12.78 80.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.548 ' CG ' ' CG2' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -115.56 175.9 5.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -1.149 . . . . 0.0 109.475 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -137.34 138.43 39.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.94 122.63 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.666 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -91.62 158.03 41.01 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.283 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -5.73 15.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.601 2.201 . . . . 0.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -87.85 -49.81 6.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ARG . . . 141.29 82.83 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 163.56 -166.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -1.145 . . . . 0.0 109.548 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -145.85 138.47 25.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.818 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.73 165.4 31.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.669 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.41 131.13 10.39 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.571 2.181 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -107.46 42.15 1.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 109.38 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -120.42 124.65 45.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.503 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.43 104.56 3.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.449 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.82 172.92 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.1 OUTLIER -87.89 -74.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER 176.9 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.432 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.01 -166.94 42.91 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 -92.86 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.18 -178.17 3.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.103 . . . . 0.0 109.242 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 27.3 m -127.53 -177.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.79 127.88 32.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.69 56.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.2 m-85 -107.51 111.86 24.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.8 126.85 30.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 109.284 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 172.34 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.662 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -148.56 159.56 38.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.274 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.1 Cg_endo -77.32 -3.68 13.93 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.487 2.124 . . . . 0.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -89.55 16.69 7.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.448 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.92 39.95 96.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 1.2 ptm180 -153.19 -171.74 4.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -1.085 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 155.1 50.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -133.94 149.85 72.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 35.8 Cg_endo -77.95 109.7 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.751 2.301 . . . . 0.0 110.774 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 t -101.89 43.84 1.05 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.367 -0.833 . . . . 0.0 109.308 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.89 102.86 2.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 60.57 -178.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.042 -1.036 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.394 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -55.96 130.97 45.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.05 127.07 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.53 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.57 88.53 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.19 144.83 5.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.8 51.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -93.9 -150.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -1.199 . . . . 0.0 109.537 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t -97.23 -171.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -79.21 129.18 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 109.415 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 22' ' ' THR . . . 75.47 16.31 80.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -93.28 109.63 21.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -1.148 . . . . 0.0 109.366 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.0 mtp -64.95 152.48 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -111.71 157.52 20.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.1 p -131.99 155.02 81.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.68 -24.4 8.82 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.566 2.177 . . . . 0.0 110.195 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -52.54 64.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.842 . . . . 0.0 109.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.41 44.56 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.06 143.94 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -1.173 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.574 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -82.99 155.08 24.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -134.68 134.79 22.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.28 131.4 9.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.543 2.162 . . . . 0.0 110.386 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 10' ' ' GLY . 1.8 t -115.74 54.17 0.82 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -116.24 51.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.295 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -45.89 172.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.808 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.432 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 2' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 48.3 m-20 -165.0 143.94 6.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.131 -0.981 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -107.17 -86.94 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.22 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -78.8 163.01 25.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.215 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.38 70.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 -171.54 34.75 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.489 ' HB2' ' NH1' ' A' ' 13' ' ' ARG . 13.3 m -131.66 -142.87 0.23 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -1.102 . . . . 0.0 109.284 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m -136.26 172.29 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 0.0 109.657 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.31 55.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 22' ' ' THR . . . 77.18 28.29 58.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -123.63 110.24 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.484 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 156.16 9.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' NH1' ' HB2' ' A' ' 7' ' ' CYS . 11.3 mmt180 -109.25 148.48 30.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.306 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -136.86 150.56 70.18 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 -19.18 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.606 2.204 . . . . 0.0 110.28 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -53.6 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.02 40.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -173.53 143.76 1.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.3 m -84.12 150.44 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -125.72 150.46 68.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.4 Cg_endo -78.04 131.15 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.672 2.248 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 10' ' ' GLY . 4.9 t -86.76 51.04 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 21' ' ' PRO . 20.8 m-85 -90.99 54.41 2.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.466 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 56.5 -93.06 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.509 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.265 0.555 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 3' ' ' PHE . 1.2 m-20 -111.25 81.09 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' ASN . 6.2 m-85 45.12 44.66 8.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 133.26 52.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.4 -107.28 1.02 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.56 177.23 37.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 m -99.82 158.19 15.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.08 . . . . 0.0 109.506 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -147.55 178.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.75 112.24 5.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.638 ' O ' HG22 ' A' ' 22' ' ' THR . . . 110.33 6.27 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.51 102.58 14.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.443 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.64 106.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.2 111.11 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -69.69 151.04 96.61 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -10.21 17.1 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.55 2.167 . . . . 0.0 110.45 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.23 -47.78 40.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.59 41.54 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -158.95 175.57 13.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -1.195 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.42 117.73 24.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -105.5 159.41 29.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.321 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.27 129.94 9.83 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.664 2.242 . . . . 0.0 110.501 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.9 t -122.9 42.01 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.99 114.75 24.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -108.63 -35.92 6.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.427 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -164.68 48.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.247 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -45.08 -72.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.469 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -165.06 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.74 -94.48 2.0 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.01 165.77 5.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 m -105.71 155.62 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -1.216 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.93 174.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.369 -0.832 . . . . 0.0 109.475 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.56 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.355 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.704 ' O ' HG22 ' A' ' 22' ' ' THR . . . 83.3 8.01 85.86 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.11 96.87 6.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -1.181 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 144.24 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.58 108.45 19.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -71.09 156.06 92.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 0.0 109.394 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.34 -7.09 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.556 2.171 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -79.13 -27.83 42.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.71 28.99 2.15 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -140.94 -160.35 1.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 109.355 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.37 151.93 45.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.581 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 1.1 ptpt -134.59 149.83 71.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.512 ' CB ' ' CE2' ' A' ' 23' ' ' PHE . 35.9 Cg_endo -78.01 143.08 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.518 2.145 . . . . 0.0 110.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.8 t -140.5 53.77 1.62 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' CE2' ' CB ' ' A' ' 21' ' ' PRO . 2.9 p90 -121.01 57.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.59 112.84 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 2' ' ' ASN . 8.7 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.271 0.558 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 3.5 m-80 61.9 -90.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.547 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.96 91.73 3.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m 50.52 -168.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.93 -51.05 59.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 54.32 -117.01 7.01 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -82.49 155.66 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -1.146 . . . . 0.0 109.434 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 m -43.93 165.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 127.01 31.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 22' ' ' THR . . . 109.04 -26.85 14.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 4.1 m-85 -86.31 101.57 13.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtp -53.62 161.4 1.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.135 -0.978 . . . . 0.0 109.586 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -101.8 110.41 22.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.358 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -79.8 156.32 75.11 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.25 2.96 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.678 2.252 . . . . 0.0 110.458 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -99.27 11.44 39.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 24.52 62.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.8 -170.33 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.498 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 51.2 m -140.8 153.67 45.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 mmtp -135.28 155.63 78.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 147.72 24.21 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 10' ' ' GLY . 6.8 t -115.67 34.19 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.17 -5.07 23.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -68.6 -14.87 63.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.517 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -103.89 -8.57 19.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.629 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 58.56 70.5 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -43.43 6.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.597 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.89 -16.6 7.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.62 -130.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.401 ' SG ' ' HG2' ' A' ' 13' ' ' ARG . 56.4 m -80.15 176.15 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -1.165 . . . . 0.0 109.501 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 11' ' ' TYR . 15.4 m -105.95 -171.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.17 117.51 18.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.57 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.5 30.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 8' ' ' VAL . 7.5 m-85 -118.93 96.53 5.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -1.177 . . . . 0.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -43.84 153.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.29 170.84 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.332 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 p -147.2 155.01 46.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.42 -19.03 13.5 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.696 2.264 . . . . 0.0 110.303 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.64 -61.54 1.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.65 68.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.83 -171.55 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -1.201 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -130.24 137.34 49.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.289 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.75 166.96 18.17 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.54 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.684 2.256 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.38 54.61 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.275 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.556 ' C ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -125.6 -15.76 5.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER 42.28 52.6 4.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.114 -0.991 . . . . 0.0 109.318 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.591 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -121.79 89.45 3.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.93 . . . . 0.0 109.579 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -82.48 134.69 35.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 t -152.94 -177.28 6.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.121 -0.987 . . . . 0.0 109.483 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.3 -165.04 13.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.31 152.78 36.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.5 m -112.67 -56.56 2.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.4 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t -149.62 -172.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -80.5 122.55 27.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 22' ' ' THR . . . 84.36 3.38 88.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.56 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 2.7 m-85 -92.18 149.44 21.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -1.193 . . . . 0.0 109.542 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 tpt -108.94 151.55 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.314 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -98.34 161.33 13.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.801 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.5 p -125.91 159.02 63.64 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.87 . . . . 0.0 109.398 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.7 Cg_endo -77.95 -12.53 16.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.607 2.205 . . . . 0.0 110.601 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.82 -55.6 3.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.26 60.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -162.89 158.18 22.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -1.187 . . . . 0.0 109.523 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -108.95 142.91 38.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -126.75 139.04 33.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.98 . . . . 0.0 109.437 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.29 117.14 3.73 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.476 2.118 . . . . 0.0 110.506 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 10' ' ' GLY . 9.9 t -107.16 31.81 5.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -153.94 88.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.334 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -137.57 86.71 2.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.453 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.37 78.11 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.289 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.88 127.28 31.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.658 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 -46.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.13 -29.26 12.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.35 -169.16 25.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 m -94.28 -66.98 0.88 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -1.128 . . . . 0.0 109.512 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 7' ' ' CYS . 16.9 m -158.08 156.51 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.79 126.01 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.62 12.62 27.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -105.77 121.94 45.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 0.0 109.442 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.35 128.99 38.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.842 . . . . 0.0 109.434 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.83 138.26 31.62 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.3 p -91.06 156.41 44.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.8 0.29 9.96 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.697 2.264 . . . . 0.0 110.417 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.2 -56.27 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 79.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 178.92 130.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -1.115 . . . . 0.0 109.621 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -89.35 131.33 35.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -123.5 152.06 64.25 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.29 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 35.6 Cg_endo -77.05 156.4 34.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.555 2.17 . . . . 0.0 110.345 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -111.76 31.83 5.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -144.74 175.35 10.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.87 154.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.446 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -92.92 -50.83 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.53 38.82 5.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.35 -170.61 3.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.75 -109.34 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.53 149.81 5.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.21 140.97 29.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.512 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m -118.04 -175.04 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.13 123.2 20.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 22' ' ' THR . . . 94.86 14.43 49.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.501 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 4.1 m-85 -115.84 97.28 6.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' TYR . 7.6 tpt -45.21 108.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -72.56 142.83 48.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.444 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 1.6 p -114.04 158.36 39.6 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.63 -36.91 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.695 2.263 . . . . 0.0 110.386 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -51.53 -66.71 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.72 48.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -153.07 177.8 10.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 109.498 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.5 m -126.77 141.26 51.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -118.93 145.47 37.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.0 Cg_endo -78.43 153.47 27.29 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.0 110.375 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 67.6 p -111.25 37.95 2.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -126.28 10.18 7.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.21 -157.07 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.563 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.385 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 2' ' ' ASN . 16.5 tt0 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 0.9 OUTLIER 66.07 -174.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.935 . . . . 0.0 109.384 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.05 -60.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.2 p -155.02 136.25 14.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.05 104.76 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.16 -113.53 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.3 m -128.27 -73.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.196 -1.179 . . . . 0.0 109.459 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 11' ' ' TYR . 12.4 m -150.2 166.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.57 134.92 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.99 26.61 57.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.758 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.56 110.95 13.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -1.181 . . . . 0.0 109.588 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 117.68 12.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -70.77 -176.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.386 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.14 155.62 43.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.528 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.73 -16.72 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 110.601 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.27 -44.91 70.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.87 38.59 0.23 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.2 179.13 7.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -1.115 . . . . 0.0 109.423 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.3 m -117.15 115.4 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.72 156.09 35.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.45 -170.93 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.592 2.194 . . . . 0.0 110.461 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t -131.84 26.94 4.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -106.74 -34.96 7.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.547 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 -37.18 9.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.399 -0.813 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 118.102 -0.952 . . . . 0.0 109.387 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.78 145.11 41.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 22' ' ' THR . . . 89.71 -5.66 83.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' MET . 3.2 m-30 -100.8 91.36 4.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -1.142 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' TYR . 2.5 mmt -43.49 133.17 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.626 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.12 99.73 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 149.6 30.32 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.93 0.87 9.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.742 2.295 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.08 -51.07 3.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.45 55.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.43 -179.31 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 1.3 m -133.84 132.73 40.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.968 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -129.28 139.01 34.41 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.372 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.1 Cg_endo -78.73 133.45 11.47 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.516 2.144 . . . . 0.0 110.6 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 10' ' ' GLY . 2.1 t . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.302 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -82.09 110.26 17.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.882 . . . . 0.0 109.156 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 22' ' ' THR . . . 97.02 1.49 59.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' MET . 1.8 m-85 -98.79 96.36 7.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -1.218 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' TYR . 9.1 mtt -44.39 165.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 131.23 50.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.982 . . . . 0.0 109.898 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.482 HG21 ' HD2' ' A' ' 20' ' ' LYS . 12.4 p -105.95 153.38 40.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.273 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.3 1.02 9.38 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.495 2.13 . . . . 0.0 110.427 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.41 -36.34 20.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.967 . . . . 0.0 109.398 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.38 -4.84 4.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -112.6 160.63 17.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -109.61 167.5 10.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 14' ' ' THR . 12.3 mttt -142.42 148.59 47.91 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 158.52 31.26 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.638 2.225 . . . . 0.0 110.272 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 10' ' ' GLY . 7.8 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 11' ' ' TYR . 3.3 m . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.65 152.87 40.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.01 12.39 68.23 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' A' ' 8' ' ' VAL . 4.5 m-85 -116.65 97.96 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.92 136.27 55.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 tmm_? -78.48 121.72 24.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -86.58 156.63 56.09 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 -5.55 15.22 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.636 2.224 . . . . 0.0 110.418 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -91.86 2.04 56.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.67 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.46 56.02 3.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -157.89 148.8 21.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.432 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.92 112.6 24.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 0.0 109.5 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.05 150.96 43.2 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 143.63 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.616 2.211 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 109.621 -179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 5.2 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.279 0.562 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.11 156.41 39.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.761 ' O ' HG22 ' A' ' 22' ' ' THR . . . 68.7 9.4 58.9 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -110.93 105.16 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.45 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.464 ' SD ' ' HB ' ' A' ' 22' ' ' THR . 2.4 mtp -56.91 165.64 1.19 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mtm-85 -115.91 133.59 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.2 p -113.45 156.05 43.86 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.992 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -19.27 12.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.597 2.198 . . . . 0.0 110.283 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -18.88 65.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.05 33.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.85 -160.78 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -1.195 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.44 155.12 42.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -131.08 142.36 45.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.193 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 168.24 21.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 110.551 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 10' ' ' GLY . 5.9 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.548 ' CG2' ' CG ' ' A' ' 11' ' ' TYR . 19.3 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.63 137.23 52.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 109.378 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.28 12.78 80.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.548 ' CG ' ' CG2' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -115.56 175.9 5.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -1.149 . . . . 0.0 109.475 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -137.34 138.43 39.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.94 122.63 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.666 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -91.62 158.03 41.01 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.283 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -5.73 15.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.601 2.201 . . . . 0.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -87.85 -49.81 6.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ARG . . . 141.29 82.83 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 163.56 -166.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -1.145 . . . . 0.0 109.548 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -145.85 138.47 25.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.818 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.73 165.4 31.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.669 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.41 131.13 10.39 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.571 2.181 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 109.38 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 27.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.79 127.88 32.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.69 56.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.2 m-85 -107.51 111.86 24.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.8 126.85 30.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 109.284 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 172.34 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.662 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -148.56 159.56 38.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.274 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.1 Cg_endo -77.32 -3.68 13.93 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.487 2.124 . . . . 0.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -89.55 16.69 7.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.448 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.92 39.95 96.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 1.2 ptm180 -153.19 -171.74 4.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -1.085 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 155.1 50.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -133.94 149.85 72.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 35.8 Cg_endo -77.95 109.7 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.751 2.301 . . . . 0.0 110.774 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.367 -0.833 . . . . 0.0 109.308 179.758 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -79.21 129.18 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 109.415 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 22' ' ' THR . . . 75.47 16.31 80.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -93.28 109.63 21.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -1.148 . . . . 0.0 109.366 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.0 mtp -64.95 152.48 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -111.71 157.52 20.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.1 p -131.99 155.02 81.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.68 -24.4 8.82 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.566 2.177 . . . . 0.0 110.195 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -52.54 64.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.842 . . . . 0.0 109.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.41 44.56 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.06 143.94 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -1.173 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.574 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -82.99 155.08 24.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -134.68 134.79 22.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.28 131.4 9.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.543 2.162 . . . . 0.0 110.386 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 10' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.657 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.31 55.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 22' ' ' THR . . . 77.18 28.29 58.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -123.63 110.24 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.484 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 156.16 9.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -109.25 148.48 30.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.306 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -136.86 150.56 70.18 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 -19.18 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.606 2.204 . . . . 0.0 110.28 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -53.6 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.02 40.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -173.53 143.76 1.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.3 m -84.12 150.44 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -125.72 150.46 68.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 131.15 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.672 2.248 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 10' ' ' GLY . 4.9 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.75 112.24 5.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.638 ' O ' HG22 ' A' ' 22' ' ' THR . . . 110.33 6.27 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.51 102.58 14.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.443 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.64 106.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.2 111.11 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -69.69 151.04 96.61 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -10.21 17.1 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.55 2.167 . . . . 0.0 110.45 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.23 -47.78 40.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.59 41.54 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -158.95 175.57 13.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -1.195 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.42 117.73 24.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -105.5 159.41 29.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.321 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.27 129.94 9.83 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.664 2.242 . . . . 0.0 110.501 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.9 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.56 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.355 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.704 ' O ' HG22 ' A' ' 22' ' ' THR . . . 83.3 8.01 85.86 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.11 96.87 6.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -1.181 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 144.24 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.58 108.45 19.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -71.09 156.06 92.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 0.0 109.394 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.34 -7.09 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.556 2.171 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -79.13 -27.83 42.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.71 28.99 2.15 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -140.94 -160.35 1.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 109.355 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.37 151.93 45.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.581 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 1.1 ptpt -134.59 149.83 71.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 35.9 Cg_endo -78.01 143.08 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.518 2.145 . . . . 0.0 110.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.8 t . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.524 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.236 0.541 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 127.01 31.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 22' ' ' THR . . . 109.04 -26.85 14.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 4.1 m-85 -86.31 101.57 13.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtp -53.62 161.4 1.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.135 -0.978 . . . . 0.0 109.586 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -101.8 110.41 22.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.358 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -79.8 156.32 75.11 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.25 2.96 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.678 2.252 . . . . 0.0 110.458 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -99.27 11.44 39.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 24.52 62.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.8 -170.33 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.498 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 51.2 m -140.8 153.67 45.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 mmtp -135.28 155.63 78.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 147.72 24.21 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 10' ' ' GLY . 6.8 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.511 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 11' ' ' TYR . 15.4 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.17 117.51 18.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.57 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.5 30.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 8' ' ' VAL . 7.5 m-85 -118.93 96.53 5.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -1.177 . . . . 0.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -43.84 153.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 170.84 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.332 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 p -147.2 155.01 46.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.42 -19.03 13.5 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.696 2.264 . . . . 0.0 110.303 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.64 -61.54 1.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.65 68.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.83 -171.55 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -1.201 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -130.24 137.34 49.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.289 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.75 166.96 18.17 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.54 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.684 2.256 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.275 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -80.5 122.55 27.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 22' ' ' THR . . . 84.36 3.38 88.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.56 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 2.7 m-85 -92.18 149.44 21.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -1.193 . . . . 0.0 109.542 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 tpt -108.94 151.55 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.314 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -98.34 161.33 13.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.801 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.5 p -125.91 159.02 63.64 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.87 . . . . 0.0 109.398 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.7 Cg_endo -77.95 -12.53 16.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.607 2.205 . . . . 0.0 110.601 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.82 -55.6 3.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.26 60.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -162.89 158.18 22.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -1.187 . . . . 0.0 109.523 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -108.95 142.91 38.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -126.75 139.04 33.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.98 . . . . 0.0 109.437 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.29 117.14 3.73 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.476 2.118 . . . . 0.0 110.506 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 10' ' ' GLY . 9.9 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 11' ' ' TYR . 16.9 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.79 126.01 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.62 12.62 27.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -105.77 121.94 45.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 0.0 109.442 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.35 128.99 38.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.842 . . . . 0.0 109.434 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.83 138.26 31.62 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.3 p -91.06 156.41 44.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.8 0.29 9.96 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.697 2.264 . . . . 0.0 110.417 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.2 -56.27 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 79.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 178.92 130.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -1.115 . . . . 0.0 109.621 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -89.35 131.33 35.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -123.5 152.06 64.25 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.29 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 35.6 Cg_endo -77.05 156.4 34.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.555 2.17 . . . . 0.0 110.345 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 -179.837 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.13 123.2 20.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 22' ' ' THR . . . 94.86 14.43 49.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.501 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 4.1 m-85 -115.84 97.28 6.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' TYR . 7.6 tpt -45.21 108.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -72.56 142.83 48.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.444 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 1.6 p -114.04 158.36 39.6 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.63 -36.91 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.695 2.263 . . . . 0.0 110.386 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -51.53 -66.71 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.72 48.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -153.07 177.8 10.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 109.498 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.5 m -126.77 141.26 51.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -118.93 145.47 37.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.0 Cg_endo -78.43 153.47 27.29 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.0 110.375 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 67.6 p . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 11' ' ' TYR . 12.4 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.27 0.557 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.57 134.92 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.99 26.61 57.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.758 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.56 110.95 13.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -1.181 . . . . 0.0 109.588 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 117.68 12.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -70.77 -176.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.386 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.14 155.62 43.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.528 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.73 -16.72 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 110.601 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.27 -44.91 70.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.87 38.59 0.23 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.2 179.13 7.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -1.115 . . . . 0.0 109.423 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.3 m -117.15 115.4 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.72 156.09 35.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.45 -170.93 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.592 2.194 . . . . 0.0 110.461 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 109.264 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 51.46 45.05 28.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.39 -62.57 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -74.68 -150.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.159 -0.963 . . . . 0.0 109.68 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.84 -153.18 17.79 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.93 127.21 8.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.49 179.29 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 109.45 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.5 m -102.87 178.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.87 . . . . 0.0 109.417 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.78 145.11 41.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 22' ' ' THR . . . 89.71 -5.66 83.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' MET . 3.2 m-30 -100.8 91.36 4.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.259 -1.142 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' TYR . 2.5 mmt -43.49 133.17 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.626 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.12 99.73 12.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.68 149.6 30.32 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.93 0.87 9.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.742 2.295 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.08 -51.07 3.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.45 55.61 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.43 -179.31 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . 1.3 m -133.84 132.73 40.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.968 . . . . 0.0 109.528 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -129.28 139.01 34.41 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.372 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.1 Cg_endo -78.73 133.45 11.47 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.516 2.144 . . . . 0.0 110.6 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 10' ' ' GLY . 2.1 t -118.08 67.78 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.302 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -99.15 47.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.575 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.93 110.25 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.958 . . . . 0.0 109.406 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.527 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.72 108.09 19.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.554 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -106.26 13.95 28.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.242 -0.912 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -50.79 140.55 14.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.05 130.2 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.22 94.23 0.25 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.07 -151.05 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -1.159 . . . . 0.0 109.376 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t -71.38 -173.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.342 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.695 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -82.09 110.26 17.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.882 . . . . 0.0 109.156 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.665 ' O ' HG22 ' A' ' 22' ' ' THR . . . 97.02 1.49 59.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' MET . 1.8 m-85 -98.79 96.36 7.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.13 -1.218 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' TYR . 9.1 mtt -44.39 165.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 131.23 50.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.982 . . . . 0.0 109.898 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.482 HG21 ' HD2' ' A' ' 20' ' ' LYS . 12.4 p -105.95 153.38 40.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.273 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.3 1.02 9.38 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.495 2.13 . . . . 0.0 110.427 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.41 -36.34 20.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.967 . . . . 0.0 109.398 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.38 -4.84 4.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -112.6 160.63 17.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -1.14 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -109.61 167.5 10.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 14' ' ' THR . 12.3 mttt -142.42 148.59 47.91 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 158.52 31.26 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.638 2.225 . . . . 0.0 110.272 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 10' ' ' GLY . 7.8 t -123.19 48.73 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -90.94 166.62 12.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.191 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.06 46.58 2.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.64 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.423 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.318 0.58 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 9.6 p30 177.22 151.65 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 1.4 m-85 65.1 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 109.184 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 176.52 11.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.601 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.05 174.31 46.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.51 -108.18 3.25 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.551 ' O ' HG13 ' A' ' 8' ' ' VAL . 5.0 m -94.0 -71.78 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -1.201 . . . . 0.0 109.558 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.598 HG23 ' CD1' ' A' ' 11' ' ' TYR . 3.3 m -157.23 174.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 109.436 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.65 152.87 40.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.473 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.01 12.39 68.23 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD1' HG23 ' A' ' 8' ' ' VAL . 4.5 m-85 -116.65 97.96 6.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.92 136.27 55.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 tmm_? -78.48 121.72 24.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -86.58 156.63 56.09 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 -5.55 15.22 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.636 2.224 . . . . 0.0 110.418 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -91.86 2.04 56.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.67 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.46 56.02 3.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -157.89 148.8 21.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.432 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -94.92 112.6 24.3 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 0.0 109.5 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.05 150.96 43.2 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 143.63 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.616 2.211 . . . . 0.0 110.437 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -130.38 52.08 2.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.177 -0.952 . . . . 0.0 109.621 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -135.03 108.37 7.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 0.0 109.152 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.96 15.88 14.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.801 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.385 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.26 149.52 19.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -127.43 58.27 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.1 36.82 1.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.27 59.38 7.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.68 38.81 2.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.41 148.75 41.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.296 -1.12 . . . . 0.0 109.54 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 5.2 m -48.54 170.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.11 156.41 39.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.363 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.761 ' O ' HG22 ' A' ' 22' ' ' THR . . . 68.7 9.4 58.9 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -110.93 105.16 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.45 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.464 ' SD ' ' HB ' ' A' ' 22' ' ' THR . 2.4 mtp -56.91 165.64 1.19 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mtm-85 -115.91 133.59 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.2 p -113.45 156.05 43.86 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.992 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -19.27 12.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.597 2.198 . . . . 0.0 110.283 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -18.88 65.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.861 . . . . 0.0 109.47 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.11 1.05 33.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.85 -160.78 0.72 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -1.195 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.44 155.12 42.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -131.08 142.36 45.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.193 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 168.24 21.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 110.551 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 10' ' ' GLY . 5.9 t -137.99 76.68 1.59 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.54 82.67 1.69 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.537 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.62 137.1 20.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.465 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.423 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -170.43 178.82 3.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.64 96.91 0.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 p -149.06 162.32 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.215 -0.928 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.46 62.18 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.93 -141.15 4.76 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.596 ' O ' HG13 ' A' ' 8' ' ' VAL . 98.0 m -89.73 -92.22 0.13 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.218 -1.166 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 7' ' ' CYS . 19.3 m -160.06 167.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.487 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.63 137.23 52.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 109.378 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.28 12.78 80.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.548 ' CG ' ' CG2' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -115.56 175.9 5.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -1.149 . . . . 0.0 109.475 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -137.34 138.43 39.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.94 122.63 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.666 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -91.62 158.03 41.01 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.283 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.08 -5.73 15.34 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.601 2.201 . . . . 0.0 110.535 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -87.85 -49.81 6.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.356 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 18' ' ' ARG . . . 141.29 82.83 0.07 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER 163.56 -166.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -1.145 . . . . 0.0 109.548 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -145.85 138.47 25.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.392 -0.818 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.73 165.4 31.92 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.669 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.41 131.13 10.39 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.571 2.181 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -107.46 42.15 1.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 109.38 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -120.42 124.65 45.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.503 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.43 104.56 3.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.449 -179.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.82 172.92 6.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' SER . 0.1 OUTLIER -87.89 -74.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER 176.9 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.432 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.01 -166.94 42.91 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 -92.86 0.09 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.0 m -116.18 -178.17 3.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -1.103 . . . . 0.0 109.242 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 27.3 m -127.53 -177.51 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.79 127.88 32.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.69 56.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 7.2 m-85 -107.51 111.86 24.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.8 126.85 30.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.185 -0.947 . . . . 0.0 109.284 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 172.34 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.662 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 77.7 p -148.56 159.56 38.3 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.274 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.1 Cg_endo -77.32 -3.68 13.93 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.487 2.124 . . . . 0.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.445 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -89.55 16.69 7.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.448 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.92 39.95 96.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 1.2 ptm180 -153.19 -171.74 4.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.355 -1.085 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.34 155.1 50.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -133.94 149.85 72.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 35.8 Cg_endo -77.95 109.7 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.751 2.301 . . . . 0.0 110.774 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.3 t -101.89 43.84 1.05 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.367 -0.833 . . . . 0.0 109.308 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.89 102.86 2.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.347 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 60.57 -178.63 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.042 -1.036 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.394 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -55.96 130.97 45.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 109.521 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.05 127.07 2.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.53 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.57 88.53 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.19 144.83 5.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.8 51.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -93.9 -150.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -1.199 . . . . 0.0 109.537 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t -97.23 -171.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.347 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -79.21 129.18 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 109.415 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 22' ' ' THR . . . 75.47 16.31 80.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -93.28 109.63 21.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -1.148 . . . . 0.0 109.366 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.0 mtp -64.95 152.48 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.702 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -111.71 157.52 20.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.1 p -131.99 155.02 81.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.68 -24.4 8.82 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.566 2.177 . . . . 0.0 110.195 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.79 -52.54 64.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.842 . . . . 0.0 109.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.41 44.56 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.06 143.94 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -1.173 . . . . 0.0 109.561 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.574 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -82.99 155.08 24.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.342 -0.849 . . . . 0.0 109.439 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -134.68 134.79 22.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.404 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.28 131.4 9.66 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.543 2.162 . . . . 0.0 110.386 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 10' ' ' GLY . 1.8 t -115.74 54.17 0.82 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -116.24 51.62 0.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.295 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 23' ' ' PHE . 0.7 OUTLIER -45.89 172.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.808 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.432 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' A' ' 2' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 48.3 m-20 -165.0 143.94 6.65 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.131 -0.981 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -107.17 -86.94 0.49 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.22 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -78.8 163.01 25.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.0 109.215 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.38 70.92 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 -171.54 34.75 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.489 ' HB2' ' NH1' ' A' ' 13' ' ' ARG . 13.3 m -131.66 -142.87 0.23 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.327 -1.102 . . . . 0.0 109.284 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m -136.26 172.29 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.06 -1.025 . . . . 0.0 109.657 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.31 55.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 22' ' ' THR . . . 77.18 28.29 58.51 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -123.63 110.24 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.484 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 156.16 9.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' NH1' ' HB2' ' A' ' 7' ' ' CYS . 11.3 mmt180 -109.25 148.48 30.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.306 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -136.86 150.56 70.18 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.29 -19.18 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.606 2.204 . . . . 0.0 110.28 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -53.6 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.02 40.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -173.53 143.76 1.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.3 m -84.12 150.44 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -125.72 150.46 68.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 35.4 Cg_endo -78.04 131.15 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.672 2.248 . . . . 0.0 110.295 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 10' ' ' GLY . 4.9 t -86.76 51.04 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 21' ' ' PRO . 20.8 m-85 -90.99 54.41 2.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -0.874 . . . . 0.0 109.466 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 56.5 -93.06 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.509 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.265 0.555 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 3' ' ' PHE . 1.2 m-20 -111.25 81.09 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' ASN . 6.2 m-85 45.12 44.66 8.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 133.26 52.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.252 -0.905 . . . . 0.0 109.5 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.4 -107.28 1.02 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.56 177.23 37.92 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 m -99.82 158.19 15.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.08 . . . . 0.0 109.506 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -147.55 178.1 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.75 112.24 5.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.519 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.638 ' O ' HG22 ' A' ' 22' ' ' THR . . . 110.33 6.27 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.51 102.58 14.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.443 ' HB2' ' HB ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -51.64 106.09 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.2 111.11 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 p -69.69 151.04 96.61 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.68 -10.21 17.1 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.55 2.167 . . . . 0.0 110.45 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.23 -47.78 40.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.373 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 147.59 41.54 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -158.95 175.57 13.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -1.195 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.42 117.73 24.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -105.5 159.41 29.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.321 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.27 129.94 9.83 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.664 2.242 . . . . 0.0 110.501 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.9 t -122.9 42.01 3.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.851 . . . . 0.0 109.269 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.99 114.75 24.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.596 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -108.63 -35.92 6.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.295 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.427 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -164.68 48.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.247 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -45.08 -72.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.469 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -165.06 -72.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.74 -94.48 2.0 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.01 165.77 5.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 m -105.71 155.62 19.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.132 -1.216 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.93 174.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.369 -0.832 . . . . 0.0 109.475 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.44 146.56 50.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.355 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.704 ' O ' HG22 ' A' ' 22' ' ' THR . . . 83.3 8.01 85.86 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.11 96.87 6.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -1.181 . . . . 0.0 109.467 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.81 144.24 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.58 108.45 19.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.9 p -71.09 156.06 92.42 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.436 -0.79 . . . . 0.0 109.394 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.34 -7.09 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.556 2.171 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -79.13 -27.83 42.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.71 28.99 2.15 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -140.94 -160.35 1.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -1.109 . . . . 0.0 109.355 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.37 151.93 45.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.581 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 1.1 ptpt -134.59 149.83 71.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.512 ' CB ' ' CE2' ' A' ' 23' ' ' PHE . 35.9 Cg_endo -78.01 143.08 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.518 2.145 . . . . 0.0 110.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 10' ' ' GLY . 8.8 t -140.5 53.77 1.62 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.524 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' CE2' ' CB ' ' A' ' 21' ' ' PRO . 2.9 p90 -121.01 57.95 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.564 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.59 112.84 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.435 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.116 -0.945 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 2' ' ' ASN . 8.7 tt0 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.271 0.558 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 3.5 m-80 61.9 -90.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.547 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.96 91.73 3.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m 50.52 -168.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.505 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.93 -51.05 59.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 54.32 -117.01 7.01 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -82.49 155.66 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -1.146 . . . . 0.0 109.434 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 m -43.93 165.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 127.01 31.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 22' ' ' THR . . . 109.04 -26.85 14.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 4.1 m-85 -86.31 101.57 13.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.1 mtp -53.62 161.4 1.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.135 -0.978 . . . . 0.0 109.586 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -101.8 110.41 22.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.327 -0.858 . . . . 0.0 109.358 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 p -79.8 156.32 75.11 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.25 2.96 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.678 2.252 . . . . 0.0 110.458 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -99.27 11.44 39.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 24.52 62.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.8 -170.33 2.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 109.498 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 51.2 m -140.8 153.67 45.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 2.0 mmtp -135.28 155.63 78.62 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.585 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.99 147.72 24.21 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 10' ' ' GLY . 6.8 t -115.67 34.19 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.17 -5.07 23.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -68.6 -14.87 63.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.517 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -103.89 -8.57 19.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.317 -0.864 . . . . 0.0 109.629 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 58.56 70.5 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -43.43 6.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.597 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.89 -16.6 7.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.62 -130.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.401 ' SG ' ' HG2' ' A' ' 13' ' ' ARG . 56.4 m -80.15 176.15 10.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -1.165 . . . . 0.0 109.501 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 11' ' ' TYR . 15.4 m -105.95 -171.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 109.437 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.17 117.51 18.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.57 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 12.5 30.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 8' ' ' VAL . 7.5 m-85 -118.93 96.53 5.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.198 -1.177 . . . . 0.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -43.84 153.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.29 170.84 7.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.426 -0.796 . . . . 0.0 109.332 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.8 p -147.2 155.01 46.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.42 -19.03 13.5 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.696 2.264 . . . . 0.0 110.303 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -66.64 -61.54 1.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.65 68.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.83 -171.55 0.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -1.201 . . . . 0.0 109.57 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -130.24 137.34 49.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.289 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.75 166.96 18.17 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.54 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.684 2.256 . . . . 0.0 110.408 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.38 54.61 1.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.275 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.556 ' C ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -125.6 -15.76 5.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 110.091 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER 42.28 52.6 4.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.114 -0.991 . . . . 0.0 109.318 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.591 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -121.79 89.45 3.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.93 . . . . 0.0 109.579 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -82.48 134.69 35.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 t -152.94 -177.28 6.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.121 -0.987 . . . . 0.0 109.483 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.3 -165.04 13.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.31 152.78 36.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.5 m -112.67 -56.56 2.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.4 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.6 t -149.62 -172.37 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.875 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.685 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -80.5 122.55 27.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.455 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.653 ' O ' HG22 ' A' ' 22' ' ' THR . . . 84.36 3.38 88.68 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.56 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 2.7 m-85 -92.18 149.44 21.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -1.193 . . . . 0.0 109.542 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.2 tpt -108.94 151.55 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.314 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -98.34 161.33 13.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.801 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.5 p -125.91 159.02 63.64 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.87 . . . . 0.0 109.398 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 35.7 Cg_endo -77.95 -12.53 16.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.607 2.205 . . . . 0.0 110.601 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.82 -55.6 3.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.26 60.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -162.89 158.18 22.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -1.187 . . . . 0.0 109.523 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -108.95 142.91 38.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -126.75 139.04 33.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.131 -0.98 . . . . 0.0 109.437 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.29 117.14 3.73 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.476 2.118 . . . . 0.0 110.506 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 10' ' ' GLY . 9.9 t -107.16 31.81 5.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -153.94 88.89 1.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.334 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -137.57 86.71 2.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.453 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -111.37 78.11 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.289 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.88 127.28 31.39 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.658 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.8 t -137.76 -46.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.394 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.13 -29.26 12.88 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.35 -169.16 25.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 m -94.28 -66.98 0.88 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -1.128 . . . . 0.0 109.512 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 7' ' ' CYS . 16.9 m -158.08 156.51 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.79 126.01 28.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.375 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.62 12.62 27.99 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -105.77 121.94 45.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 0.0 109.442 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.35 128.99 38.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.842 . . . . 0.0 109.434 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.83 138.26 31.62 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.23 -0.919 . . . . 0.0 109.479 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.3 p -91.06 156.41 44.11 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.8 0.29 9.96 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.697 2.264 . . . . 0.0 110.417 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.2 -56.27 2.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 79.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 178.92 130.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -1.115 . . . . 0.0 109.621 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -89.35 131.33 35.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -123.5 152.06 64.25 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.29 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . 35.6 Cg_endo -77.05 156.4 34.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.555 2.17 . . . . 0.0 110.345 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -111.76 31.83 5.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -144.74 175.35 10.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 65.87 154.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.468 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.446 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -92.92 -50.83 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.401 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.53 38.82 5.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.35 -170.61 3.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.75 -109.34 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.53 149.81 5.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.21 140.97 29.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.512 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 11' ' ' TYR . 28.4 m -118.04 -175.04 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.13 123.2 20.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 22' ' ' THR . . . 94.86 14.43 49.51 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.501 ' CD1' ' CG2' ' A' ' 8' ' ' VAL . 4.1 m-85 -115.84 97.28 6.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.231 -1.158 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' TYR . 7.6 tpt -45.21 108.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -72.56 142.83 48.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.281 -0.887 . . . . 0.0 109.582 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.444 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 1.6 p -114.04 158.36 39.6 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.41 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.63 -36.91 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.695 2.263 . . . . 0.0 110.386 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -51.53 -66.71 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.474 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.72 48.66 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -153.07 177.8 10.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 109.498 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.5 m -126.77 141.26 51.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -118.93 145.47 37.97 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.467 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 36.0 Cg_endo -78.43 153.47 27.29 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.0 110.375 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 10' ' ' GLY . 67.6 p -111.25 37.95 2.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -126.28 10.18 7.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.21 -157.07 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.563 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.385 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 2' ' ' ASN . 16.5 tt0 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 0.9 OUTLIER 66.07 -174.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.935 . . . . 0.0 109.384 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.05 -60.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.2 p -155.02 136.25 14.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 109.392 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.05 104.76 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.16 -113.53 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 36.3 m -128.27 -73.17 0.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.196 -1.179 . . . . 0.0 109.459 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 11' ' ' TYR . 12.4 m -150.2 166.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.57 134.92 49.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 109.699 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.99 26.61 57.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.758 ' HB2' HG23 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.56 110.95 13.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -1.181 . . . . 0.0 109.588 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 117.68 12.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -70.77 -176.56 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.386 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.14 155.62 43.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.528 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.73 -16.72 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 110.601 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -69.27 -44.91 70.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.87 38.59 0.23 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.2 179.13 7.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -1.115 . . . . 0.0 109.423 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.3 m -117.15 115.4 25.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.72 156.09 35.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.45 -170.93 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.592 2.194 . . . . 0.0 110.461 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 t -131.84 26.94 4.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 0.0 109.264 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -106.74 -34.96 7.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.547 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 -37.18 9.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.399 -0.813 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 118.102 -0.952 . . . . 0.0 109.387 -179.961 . . . . . . . . 0 0 . 1 stop_ save_